215 related articles for article (PubMed ID: 35298442)
1. Recurrence Rate for Melanoma Excised by Mohs Micrographic Surgery Without Immunostaining.
Vieira C; Jennings T; Renzi MA; Lawrence N; Decker A
Dermatol Surg; 2022 May; 48(5):492-497. PubMed ID: 35298442
[TBL] [Abstract][Full Text] [Related]
2. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
Stigall LE; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
4. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of invasive melanoma of the head and neck treated with Mohs micrographic surgery - A multicenter study.
Beal BT; Udkoff J; Aizman L; Etzkorn J; Zitelli JA; Miller CJ; Shin TM; Sobanko JF; Brodland DG
J Am Acad Dermatol; 2023 Sep; 89(3):544-550. PubMed ID: 36642331
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery for melanoma: A prospective multicenter study.
Ellison PM; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.
Burnett ME; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327
[TBL] [Abstract][Full Text] [Related]
9. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.
Zitelli JA; Brown C; Hanusa BH
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510
[TBL] [Abstract][Full Text] [Related]
11. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
12. Outcomes for Invasive Melanomas Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
Degesys CA; Powell HB; Hsia LB; Merritt BG
Dermatol Surg; 2019 Feb; 45(2):223-228. PubMed ID: 30199430
[TBL] [Abstract][Full Text] [Related]
13. Slow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients.
Seo J; Oh Y; Kim SK; Roh MR; Chung KY
Dermatol Surg; 2021 Feb; 47(2):e42-e46. PubMed ID: 33481431
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision.
Bittar PG; Bittar JM; Etzkorn JR; Brewer JD; Aizman L; Shin TM; Sobanko JF; Higgins HW; Giordano CN; Cohen JV; Pride R; Wan MT; Leitenberger JJ; Bar AA; Aasi S; Bordeaux JS; Miller CJ
J Am Acad Dermatol; 2021 Sep; 85(3):681-692. PubMed ID: 33961921
[TBL] [Abstract][Full Text] [Related]
15. Invasive Melanoma and Melanoma in Situ Treated With Modified Mohs Micrographic Surgery With En Face Permanent Sectioning: A 10-Year Retrospective Review.
Heath M; Woody M; Leitenberger J; Latour E; Bar A
Dermatol Surg; 2020 Aug; 46(8):1004-1013. PubMed ID: 31714384
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision.
Chin-Lenn L; Murynka T; McKinnon JG; Arlette JP
Dermatol Surg; 2013 Nov; 39(11):1637-45. PubMed ID: 24164702
[TBL] [Abstract][Full Text] [Related]
17. Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery.
Tate JA; Matsumoto A; Greif C; Lim J; Nijhawan RI; Srivastava D
J Am Acad Dermatol; 2024 Jun; 90(6):1226-1231. PubMed ID: 38253130
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
[TBL] [Abstract][Full Text] [Related]
19. No Recurrence in Primary Invasive Stage 1a and 1b Melanoma and Melanoma in Situ Treated With Serial Disk Staged Excision.
Ahn GS; Pousti B; Singh G; Elsensohn A; Jiang SIB
Dermatol Surg; 2022 Mar; 48(3):276-282. PubMed ID: 34935746
[TBL] [Abstract][Full Text] [Related]
20. From Centimeters to Millimeters: The Evolution of the Surgical Margins for Melanoma-A Historical Review.
Rosenthal A; Juhasz M; Lask G; Gharavi N
Dermatol Surg; 2023 Dec; 49(12):1058-1060. PubMed ID: 37656813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
